Bruce C. Schnepp

1.5k citations

21 papers · 1.1k indexed · h-index 12

Co-authors: Philip R. Johnson K. Reed Clark Ryan L. Jensen Mary J. Connell Chun‐Liang Chen Dori Klemanski Christina A. Pacak Eloísa Yuste
Topics: Virus-based gene therapy research (17 papers)HIV Research and Treatment (6 papers)Herpesvirus Infections and Treatments (5 papers)
Cited by: Virology Genetics Infectious Diseases
Journals: Nature Medicine Blood Journal of Virology
Partner nations: United States United Kingdom

In The Last Decade

Bruce C. Schnepp

19 papers receiving 1.1k citations

Peers

Countries citing papers authored by Bruce C. Schnepp

Since Specialization

Citations

This map shows the geographic impact of Bruce C. Schnepp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruce C. Schnepp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruce C. Schnepp more than expected).

Fields of papers citing papers by Bruce C. Schnepp

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bruce C. Schnepp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruce C. Schnepp. The network helps show where Bruce C. Schnepp may publish in the future.

Co-authorship network of co-authors of Bruce C. Schnepp

This figure shows the co-authorship network connecting the top 25 collaborators of Bruce C. Schnepp. A scholar is included among the top collaborators of Bruce C. Schnepp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bruce C. Schnepp. Bruce C. Schnepp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Targeted in vivo delivery of genetic medicines utilizing an engineered lentiviral vector platform results in CAR T and NK cell generation 2025 ·Molecular Therapy ·James I. Andorko,Ronnie M. Russell,Bruce C. Schnepp,(unknown),(unknown),Aoi Wakabayashi,(unknown),Thomas O’Malley,Leticia Kuri-Cervantes,Timothy D. Culp,Philip R. Johnson	8
2	Targeted In Vivo Generation of CAR T and NK Cells Utilizing an Engineered Lentiviral Vector Platform 2023 ·Blood ·James I. Andorko,Ronnie M. Russell,Bruce C. Schnepp,S. Ramesh,Debasish Boral,Thomas O’Malley,Leticia Kuri-Cervantes,(unknown),Timothy D. Culp,Philip R. Johnson	9
3	Protection against SIV in Rhesus Macaques Using Albumin and CD4-Based Vector-Mediated Gene Transfer 2020 ·Molecular Therapy — Methods & Clinical Development ·Sergei Spitsin,Bruce C. Schnepp,Mary J. Connell,(unknown),(unknown),Vasiliki Pappa,R. Don Tustin,(unknown),Philip R. Johnson,Steven D. Douglas	2
4	A003 Protocol - A Phase 1, randomized, blinded, dose-escalation study of rAAV1-PG9DP recombinant AAV vector coding for PG9 antibody in healthy male adults 2019 ·Figshare ·Frances Priddy,David Lewis,Huub C. Gelderblom,(unknown),(unknown),Celia C. LaBranche,Jonathan Hare,Josephine H. Cox,Len Dally,(unknown),David C. Montefiori,Eddy Sayeed,Jim Ackland,Jill Gilmour,Bruce C. Schnepp,(unknown),Philip J. Johnson	0
5	Adeno-associated virus vectored immunoprophylaxis to prevent HIV in healthy adults: a phase 1 randomised controlled trial 2019 ·The Lancet HIV ·Frances Priddy,David Lewis,Hans Gelderblom,Hana Hassanin,(unknown),Celia C. LaBranche,Jonathan Hare,Josephine H. Cox,Len Dally,(unknown),David C. Montefiori,Eddy Sayeed,Jim Ackland,Jill Gilmour,Bruce C. Schnepp,J. Fraser Wright,Philip R. Johnson	105
6	Engineered Expression of Broadly Neutralizing Antibodies Against Human Immunodeficiency Virus 2017 ·Annual Review of Virology ·(unknown),Osama M. Ahmed,Bruce C. Schnepp,Philip R. Johnson	2
7	Vector-Mediated Antibody Gene Transfer for Infectious Diseases 2015 ·Advances in experimental medicine and biology ·Bruce C. Schnepp,Philip R. Johnson	11
8	Recombinant Adeno-Associated Virus Vector Genomes Take the Form of Long-Lived, Transcriptionally Competent Episomes in Human Muscle 2015 ·Human Gene Therapy ·Bruce C. Schnepp,Jeffrey D. Chulay,Guojie Ye,Terence R. Flotte,Bruce C. Trapnell,Philip R. Johnson	24
9	Adeno-associated virus delivery of broadly neutralizing antibodies 2014 ·Current Opinion in HIV and AIDS ·Bruce C. Schnepp,Philip R. Johnson	23
10	Vector-Mediated In Vivo Antibody Expression 2014 ·Microbiology Spectrum ·Bruce C. Schnepp,Philip R. Johnson	8
11	Vector-mediated gene transfer engenders long-lived neutralizing activity and protection against SIV infection in monkeys 2009 ·Nature Medicine ·Philip R. Johnson,Bruce C. Schnepp,Jianchao Zhang,Mary J. Connell,(unknown),Eloísa Yuste,Ronald C. Desrosiers,K. Reed Clark	239
12	Genetic Vaccines for Anthrax Based on Recombinant Adeno-associated Virus Vectors 2008 ·Molecular Therapy ·(unknown),Jon Oscherwitz,Bruce C. Schnepp,Jana L. Jacobs,(unknown),Kemp B. Cease,Philip R. Johnson	16
13	492. Biodistribution and Integration Assessment of AAV1 gag-PR-RT(ΔRNaseH) after Intramuscular Administration in Rabbits 2006 ·Molecular Therapy ·Bruce C. Schnepp,Michael C. Soult,(unknown),Pervin Anklesaria,Philip R. Johnson,Keith Munson	0
14	Characterization of Adeno-Associated Virus Genomes Isolated from Human Tissues 2005 ·Journal of Virology ·Bruce C. Schnepp,Ryan L. Jensen,Chun‐Liang Chen,Philip R. Johnson,K. Reed Clark	169
15	Molecular Characterization of Adeno-Associated Viruses Infecting Children 2005 ·Journal of Virology ·Chun‐Liang Chen,Ryan L. Jensen,Bruce C. Schnepp,Mary J. Connell,Richard Shell,Thomas J. Sferra,Jeffrey S. Bartlett,K. Reed Clark,Philip R. Johnson	69
16	Regulation of the Drosophila Epidermal Growth Factor-Ligand Vein Is Mediated by Multiple Domains 2004 ·Genetics ·(unknown),Shu‐Huei Wang,Thomas Jacobsen,Bruce C. Schnepp,Jessica C. Price,Amanda Simcox	11
17	Novel Adeno-Associated Virus Vector Vaccine Restricts Replication of Simian Immunodeficiency Virus in Macaques 2004 ·Journal of Virology ·Philip R. Johnson,Bruce C. Schnepp,Mary J. Connell,(unknown),(unknown),Georgia R. Krivulka,Carol I. Lord,Rebekah L. Zinn,David C. Montefiori,Norman L. Letvin,K. Reed Clark	69
18	Highly Purified Recombinant Adeno-Associated Virus Vectors: Preparation and Quantitation 2003 ·Humana Press eBooks ·Bruce C. Schnepp,K. Reed Clark	3
19	Genetic Fate of Recombinant Adeno-Associated Virus Vector Genomes in Muscle 2003 ·Journal of Virology ·Bruce C. Schnepp,K. Reed Clark,Dori Klemanski,Christina A. Pacak,Philip R. Johnson	192
20	Molecular, Phenotypic, and Expression Analysis ofvein,a Gene Required for Growth of theDrosophilaWing Disc 1996 ·Developmental Biology ·Amanda Simcox,Gary Grumbling,Bruce C. Schnepp,(unknown),Evelyn Hersperger,Allen Shearn	89

About Bruce C. Schnepp

Bruce C. Schnepp is a scholar working on Virology, Genetics and Epidemiology, having authored 21 papers that have together received 1.1k indexed citations. Recurring topics across this work include Virus-based gene therapy research (17 papers), HIV Research and Treatment (6 papers) and Herpesvirus Infections and Treatments (5 papers). The work is most often cited by research in Virology (263 citations), Genetics (592 citations) and Infectious Diseases (215 citations). Bruce C. Schnepp has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Philip R. Johnson, K. Reed Clark, Ryan L. Jensen, K. Reed Clark, Mary J. Connell, Chun‐Liang Chen, Dori Klemanski, Christina A. Pacak, Eloísa Yuste and Ronald C. Desrosiers. Their work appears in journals such as Nature Medicine, Blood and Journal of Virology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact